Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
NVIDIA
NVDA
|
$59.4B |
| 2 |
Microsoft
MSFT
|
$1.86B |
| 3 |
Chipotle Mexican Grill
CMG
|
$1.69B |
| 4 |
Exxon Mobil
XOM
|
$1.35B |
| 5 |
Apple
AAPL
|
$1.19B |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.24B |
| 2 |
Broadcom
AVGO
|
$499M |
| 3 |
Apollo Global Management
APO
|
$286M |
| 4 |
Super Micro Computer
SMCI
|
$243M |
| 5 |
Trane Technologies
TT
|
$219M |
Sector Composition
| 1 | Technology | 31.9% |
| 2 | Financials | 12.27% |
| 3 | Healthcare | 11.66% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Communication Services | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Solidion Technology
STI
$9.1M
| $154K | ﹤0.01% |
280,493
+134,275
| +92% | +$73.9K |
|
|
FGNX
4002
Fundamental Global
FGNX
$18.6M
| $154K | ﹤0.01% |
162,553
-19,897
| -11% | -$18.9K |
|
|
AMRN
4003
Amarin Corp
AMRN
$311M
| $154K | ﹤0.01% |
223,551
| – | – |
|
4004
TherapeuticsMD
TXMD
$12.8M
| $154K | ﹤0.01% |
95,477
+10,689
| +13% | +$17.2K |
|
4005
Worksport
WKSP
$20.7M
| $153K | ﹤0.01% |
196,035
+55,651
| +40% | +$43.3K |
|
|
LAR
4006
Lithium Argentina AG
LAR
$555M
| $152K | ﹤0.01% |
47,603
+3,498
| +8% | +$11.1K |
|
4007
Cocrystal Pharma
COCP
$15.4M
| $151K | ﹤0.01% |
64,832
+4,400
| +7% | +$10.3K |
|
|
PET
4008
DELISTED
Wag!
PET
| $151K | ﹤0.01% |
94,273
-1,542
| -2% | -$2.47K |
|
4009
bioAffinity Technologies
BIAF
$6.89M
| $150K | ﹤0.01% |
69,600
+27,522
| +65% | +$59.4K |
|
4010
Equillium
EQ
$62.2M
| $150K | ﹤0.01% |
216,204
+16,476
| +8% | +$11.4K |
|
|
AIM
4011
AIM ImmunoTech Inc.
AIM
$6.64M
| $150K | ﹤0.01% |
401,027
+49,370
| +14% | +$18.4K |
|
|
XELA
4012
DELISTED
Exela Technologies, Inc. Common Stock
XELA
| $149K | ﹤0.01% |
61,432
+2,324
| +4% | +$5.65K |
|
4013
MEI Pharma
MEIP
$160M
| $149K | ﹤0.01% |
51,290
-1,141
| -2% | -$3.32K |
|
|
GHIX
4014
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
| $149K | ﹤0.01% |
14,147
| – | – |
|
|
SLAM
4015
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $149K | ﹤0.01% |
13,396
| – | – |
|
4016
Lesaka Technologies
LSAK
$383M
| $149K | ﹤0.01% |
31,755
| – | – |
|
|
APCX
4017
DELISTED
AppTech Payments
APCX
| $148K | ﹤0.01% |
157,288
+40,534
| +35% | +$38.1K |
|
|
VIRX
4018
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $147K | ﹤0.01% |
270,773
+18,072
| +7% | +$9.83K |
|
|
HEPS
4019
D-Market Electronic Services & Trading
HEPS
$900M
| $147K | ﹤0.01% |
66,569
| – | – |
|
|
DPCS
4020
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
| $147K | ﹤0.01% |
13,096
| – | – |
|
|
NUTX
4021
Nutex Health
NUTX
$465M
| $145K | ﹤0.01% |
244,145
-4,125,802
| -94% | -$2.46M |
|
4022
Aprea Therapeutics
APRE
$9.12M
| $145K | ﹤0.01% |
35,673
+15,452
| +76% | +$62.9K |
|
4023
Retractable Technologies
RVP
$25.1M
| $145K | ﹤0.01% |
134,222
-2,951
| -2% | -$3.19K |
|
4024
Direct Digital Holdings
DRCT
$10.4M
| $144K | ﹤0.01% |
35,722
+2,661
| +8% | +$10.7K |
|
4025
Ekso Bionics
EKSO
$9.79M
| $143K | ﹤0.01% |
135,823
+25,474
| +23% | +$26.9K |
|